RT Journal Article
SR Electronic
A1 Summers, Jaye
T1 IBREST Trial
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 14
SP 17
OP 18
DO 10.1177/1559897715593898
UL http://mdc.sagepub.com/content/15/14/17.abstract
AB In the IBREST trial, when compared with placebo, a novel targeted delivery system of peppermint oil is more effective in treating symptoms of nonconstipated irritable bowel syndrome at 4 weeks. The trial shows significant improvement in the Total IBS Symptoms Score and 4 of 8 symptom domains. Furthermore, the treatment appears safe and well tolerated.